Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

This content is for healthcare professionals only.

Please confirm you are a healthcare professional.

Yes
No

The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

VJHemOnc was official media partner of the NYC-Miami Myeloma MRD 2020 Virtual Meeting which took place on the 8th of October 2020 and was organized by MMRF & Memorial Sloan Kettering Cancer Center.
The meeting brought together leading experts in multiple myeloma who discussed the use of measurable residual disease (MRD) in clinical and trial settings, furthering our understanding of recent advances in the disease, and encouraging interactive discussion.

Watch the meeting on-demand below!

MRD in 2020: BMCTN consensus document

Luciano Costa, MD, University of Alabama at Birmingham

Watch Now
New trials with MRD focus. GRIFFIN, FORTE, ENDURANCE, MASTER, MANHATTAN

Benjamin Derman, MD, University of Chicago

Watch Now

Debates

MRD in 2020: BMCTN consensus document

Luciano Costa, MD, University of Alabama at Birmingham

Watch Now
New trials with MRD focus. GRIFFIN, FORTE, ENDURANCE, MASTER, MANHATTAN

Benjamin Derman, MD, University of Chicago

Watch Now
The content of VJHemOnc is intended for healthcare professionals